Head-to-head · WeighScore

CoreAge Rx vs GOAL.MD

By GLP-1 Scorecard · Updated October 2026

For a first purchase, we would compare GOAL.MD's month-to-month option with a confirmed CoreAge quote before committing to a prepaid year. GOAL makes the compounded reorder permission clear, but paid orders are final. CoreAge advertises lower starting prices; its conflicting renewal and refund statements need resolving before those prices can drive the decision.

Consider CoreAge after clarifying the selected price and exit terms

CoreAge product pages start at $79 a month for semaglutide and $129 for tirzepatide. Those labels do not establish your first debit, supplied quantity or treatment term. Navigation still promotes a different semaglutide starting price. Get the complete offer before treating it as cheaper than GOAL's month-to-month plan. The FAQ promises no automatic rebills and a full refund after clinical rejection. Its refund policy permits renewing plans and retains an applicable $50–$100 consultation fee. The policy makes prescription orders final after approval and pharmacy transmission; the terms use completion of clinical review and/or transmission. A separate thirty-day cutoff can apply even before shipment. Those differences matter more than a small headline saving. Our cancellation guide explains the distinction between stopping renewal and recovering an existing payment.

Read the CoreAge Rx review →

Consider GOAL for manual compounded reorders, with a short initial commitment

GOAL advertises semaglutide at $179 month-to-month or $1,188 upfront for twelve months; tirzepatide is $249 or $1,908. The $99/$159 annual equivalents require prepayment. We would compare the monthly option first if you are still judging the service. The six-month cost guide helps compare cash paid without mistaking a prepaid equivalent for a monthly charge. Its compounded billing policy requires permission before each new order, then makes the order non-refundable once payment is processed. Manual renewal controls the next purchase; it does not recover an unused prepaid balance. Confirm how a declined prescription or early treatment stop is handled before authorizing the order. GOAL's separate brand-name program adds a physician-service fee to medication purchased elsewhere. The brand page contradicts itself about automatic billing, while the terms describe auto-renewal. Do not carry the compounded program's no-autobilling promise into a brand-name comparison.

Read the GOAL.MD review →

Confirm the prescribed preparation, usable supply, shipment schedule and assigned pharmacy for either service. Our vial-label guide explains what to request. These purchasing differences do not establish interchangeable medicines or better clinical outcomes.

B+89.5/100

CoreAge Rx

Site position #1

Higher grade

vs+20.9

C68.6/100

GOAL.MD

Site position #159

Lower grade

Score comparison

CoreAge Rx has the higher recorded score — 89.5/100 to 68.6/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

CoreAge Rx scores 89.5/100 (B+).

Visit CoreAge Rx Visit GOAL.MD

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoreAge Rx +27

Dose & formulationCoreAge Rx +2

Clinical oversightCoreAge Rx +25

Labs & monitoringCoreAge Rx +37

FulfillmentCoreAge Rx +18

Contract termsCoreAge Rx +12

CoreAge Rx · top barGOAL.MD · bottom bar

The numbers

Swipe or scroll to compare both providers.

Metric	CoreAge Rx	GOAL.MD
WeighScore	89.5/100	68.6/100
Grade	B+	C
Site position	#1	#159
Semaglutide	Product page from $79/mo; navigation $99. Confirm selected quote.	$179/mo (month-to-month, compounded)
Tirzepatide	From $129/mo advertised; confirm selected charge, supply and renewal.	$249/mo (flat-dose monthly, compounded)
Coverage	US only; therapy-specific state restrictions apply	Advertises all 50 states; clinical and pharmacy eligibility apply
Brand-name access	Not confirmed	Yes
Oral / sublingual	Not confirmed	Yes

B+89.5/100

CoreAge Rx

Site position #1 · B+

Strengths

Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
Advertises the same price across doses and no membership fee
Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy

What to consider

Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
FAQ no-rebill and payment-timing statements differ from the subscription and order policy
FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation

C68.6/100

GOAL.MD

Site position #159 · C

Strengths

Compounded reorders require permission before charging
Advertised injection price stays the same across prescribed doses
Nutrition support and expedited shipping included in compounded plans
Advertises brand-name oral Wegovy access; medication costs extra

What to consider

Compounded orders become non-refundable when payment is processed
Lowest monthly equivalents require a twelve-month upfront payment
Brand-access page gives conflicting automatic-billing statements
Confirm the assigned dispensing pharmacy and its credentials
GOAL identifies a physician with historical discipline; Missouri ended restrictions in 2019 and records no current discipline at the October 2026 check

Alternatives to CoreAge Rx →Alternatives to GOAL.MD →All comparisons →

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard